Non-Hormonal Medications and Chronic Diseases
This chapter explores the relation between breast cancer risk and the use of non-hormonal medications and chronic diseases. Many drugs and diseases have been linked with breast cancer in case reports and epidemiologic studies. This chapter covers those major medications and diseases where there is adequate epidemiologic evidence for evaluation.
KeywordsBreast Cancer Systemic Lupus Erythematosus Breast Cancer Risk Multiple Sclerosis Patient Systemic Lupus Erythematosus Patient
- ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997CrossRefGoogle Scholar
- Arun B, Miller A, Isaacs K, Saxton KP, Brown P, Elledge R (2005) Accquisition of breast tissue in a biomarker modulation study using bexarotene in women at high risk of breast cancer. J Clin Oncol ASCO Annucal Meeting Proceedings. 23(16S):1002Google Scholar
- National Cancer Institute (1998) http://www.cancer/clinicaltrials.gov. Accessed 7 Nov 2007
- Singh-Ranger G, Salhab M, Mokbel K (2008) The role of cyclooxygenase-2 in breast cancer: review. Cancer Epidemiol Biomarkers Prev 109:189–198Google Scholar
- Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86(suppl):823S–835SGoogle Scholar